Nicotine - Older Adults (50+): Difference between revisions
No edit summary |
|||
Line 29: | Line 29: | ||
=Smokeless Products= | =Smokeless Products= | ||
===ENDS (NVP, E-Cigarettes, E-Cigs, Vapes)=== | |||
====2016: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896829/ Patterns of Electronic Cigarette Use Among Adults in the United States]==== | |||
*Note: "Older adults" refers to individuals aged 25-64 years. | |||
*Results: Current e-cigarette use is extremely low among never cigarette smokers (0.4%) and former smokers who quit cigarettes 4 or more years ago (0.8%). Although e-cigarette experimentation is most common among current cigarette smokers and young adults, daily use is highest among former smokers who quit in the past year (13.0%) and older adults. Compared to daily cigarette smokers, recently quit smokers were more than four times as likely to be daily users of e-cigarettes. | |||
*Conclusion: Extremely low e-cigarette use among never-smokers and longer term former smokers suggest that e-cigarettes neither promote widespread initiation nor relapse among adults. Recognition of the heterogeneity of smokers, including the time since quitting, is critical to draw accurate conclusions about patterns of e-cigarette use at the population level and its potential for public health benefit or harm. | |||
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896829/pdf/ntv237.pdf PDF Version] | |||
**Citation: Delnevo CD, Giovenco DP, Steinberg MB, Villanti AC, Pearson JL, Niaura RS, Abrams DB. Patterns of Electronic Cigarette Use Among Adults in the United States. Nicotine Tob Res. 2016 May;18(5):715-9. doi: 10.1093/ntr/ntv237. Epub 2015 Nov 2. Erratum in: Nicotine Tob Res. 2024 Dec 23;27(1):163. doi: 10.1093/ntr/ntae234. PMID: 26525063; PMCID: PMC5896829. | |||
***Acknowledgement: This research was supported in part by funding from the National Institutes of Health (R01CA19044 [CDD and MBS] and K01DA037950 [JLP]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. | |||
===Snus=== | ===Snus=== |